Search Results - "Pathologic complete response"

Microbiome and Response to Therapy in Triple Negative Breast Cancer: A Systematic Review.

Authors: Lopes M Vila Nova C Oliveira RC et al.

Source: Oncology research [Oncol Res] 2026 May 21; Vol. 34 (6), pp. 4. Date of Electronic Publication: 2026 May 21 (Print Publication: 2026).

Publication Type: Journal Article; Systematic Review; Review

Journal Info: Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE

The Schrödinger's Cat Paradox: Can MAMMI PET with ⁶⁸Ga-FAPI Determine Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Omitting Surgery?

Authors: Oflas M Simsek DH Yilmaz R et al.

Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2026 Jun; Vol. 41 (5), pp. 410-419. Date of Electronic Publication: 2025 Dec 08.

Publication Type: Journal Article

Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8852 (Electronic) Linking ISSN: 10849785 NLM ISO Abbreviation: Cancer Biother Radiopharm Subsets: MEDLINE

Neoadjuvant nivolumab plus chemotherapy in resectable NSCLC: A pharmacological outcome study.

Authors: Can O Derdiyok O

Source: Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2026 Aug; Vol. 39 (8), pp. 2535-2545.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Faculty of Pharmacy, University of Karachi Country of Publication: Pakistan NLM ID: 9426356 Publication Model: Print Cited Medium: Internet ISSN: 3105-9686 (Electronic) Linking ISSN: 1011601X NLM ISO Abbreviation: Pak J Pharm Sci Subsets: MEDLINE

Comparison of Neoadjuvant TCHP and ddAC+THP Regimens for Pathologic Complete Response in HER2-Positive Breast Cancer: A Multicenter Real-World Analysis of Systemic Inflammatory Biomarkers.

Authors: Şahin G Dişli AK Sirvan F et al.

Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2026 Jul 16; Vol. 62 (7). Date of Electronic Publication: 2026 Jul 16.

Publication Type: Journal Article; Multicenter Study; Comparative Study

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE

Image Quality Assessment of Diffusion-Weighted Imaging (DWI) and Its Impact on Apparent Diffusion Coefficient (ADC) as a Quantitative Imaging Biomarker for Predicting Response to Neoadjuvant Chemotherapy in High-Risk Early Breast Cancer.

Authors: Li W Wilmes LJ Carmona-Bozo J et al.

Source: Tomography (Ann Arbor, Mich.) [Tomography] 2026 Jun 17; Vol. 12 (6). Date of Electronic Publication: 2026 Jun 17.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101671170 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-139X (Electronic) Linking ISSN: 23791381 NLM ISO Abbreviation: Tomography Subsets: MEDLINE

Synergistic neoadjuvant radioimmunotherapy in locally advanced rectal cancer: mechanisms of pathologic response and the shift toward organ preservation.

Authors: Yan S Zhang G Jia X

Source: Frontiers in immunology [Front Immunol] 2026 Jul 15; Vol. 17, pp. 1832333. Date of Electronic Publication: 2026 Jul 15 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

An exploratory study of nimotuzumab combined with toripalimab and chemotherapy for locally advanced tonsillar cancer.

Authors: Shi J Wang Z Zhao Q et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jul 14; Vol. 17, pp. 1890647. Date of Electronic Publication: 2026 Jul 14 (Print Publication: 2026).

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials.

Authors: Ye Y Zhang L Yang Z et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jul 09; Vol. 17, pp. 1825905. Date of Electronic Publication: 2026 Jul 09 (Print Publication: 2026).

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer.

Authors: Lan J Sun X Huang X et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jul 09; Vol. 17, pp. 1836220. Date of Electronic Publication: 2026 Jul 09 (Print Publication: 2026).

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Survival outcomes of axillary de-escalation following neoadjuvant chemo-immunotherapy in clinically node-positive triple-negative breast cancer: a national cancer database study.

Authors: Li Z Qu Z Pei S et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jul 08; Vol. 17, pp. 1892648. Date of Electronic Publication: 2026 Jul 08 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer.

Authors: Song SG Cho SI Sim T et al.

Source: PloS one [PLoS One] 2026 Jul 06; Vol. 21 (7), pp. e0352979. Date of Electronic Publication: 2026 Jul 06 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Case Report: Successful R0 resection following conversion immunochemotherapy in a patient with biliary tract cancer and multiple metastases discovered after laparoscopic gallstone surgery.

Authors: Wang Y Zhang S Shen N et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jul 03; Vol. 17, pp. 1750556. Date of Electronic Publication: 2026 Jul 03 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

N^w-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer.

Authors: Mohan S Van Pelt DW Saunders JG et al.

Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2026 Jul; Vol. 9 (7), pp. e70609.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

Magnetic Resonance Imaging After Total Neoadjuvant Therapy in Rectal Cancer: Treatment-Oriented Response Assessment and Reporting for Watch-and-Wait Management.

Authors: Kim HY Jang JK Gollub MJ

Source: Korean journal of radiology [Korean J Radiol] 2026 Jul; Vol. 27 (7), pp. 652-659.

Publication Type: Journal Article; Review

Journal Info: Publisher: Korean Society of Radiology Country of Publication: Korea (South) NLM ID: 100956096 Publication Model: Print Cited Medium: Internet ISSN: 2005-8330 (Electronic) Linking ISSN: 12296929 NLM ISO Abbreviation: Korean J Radiol Subsets: MEDLINE

Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017).

Authors: Alfaro E Schelotto M Zamaro H et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Jul; Vol. 67 (8), pp. 1760-1767. Date of Electronic Publication: 2026 Apr 28.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

HER2-Low Versus HER2-Zero Breast Cancer in the Neoadjuvant Setting: Pathological Complete Response and Exploratory Survival Outcomes in a Single-Center Cohort.

Authors: Ateş Ü Keskinkılıç M Binnaz Demirkan HM

Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2026 Jun 30; Vol. 62 (7). Date of Electronic Publication: 2026 Jun 30.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE

Radiomic Analysis of MRI for Assessing Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma: A Systematic Review and Metaanalysis.

Authors: Jakipov M Tamadon A Burkitbayev Z et al.

Source: Molecular imaging [Mol Imaging] 2026 Jun 17; Vol. 25, pp. 15353508261462778. Date of Electronic Publication: 2026 Jun 17 (Print Publication: 2026).

Publication Type: Journal Article; Systematic Review; Meta-Analysis; Review

Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101120118 Publication Model: eCollection Cited Medium: Internet ISSN: 1536-0121 (Electronic) Linking ISSN: 15353508 NLM ISO Abbreviation: Mol Imaging Subsets: MEDLINE

Surgical Management of Metachronous Liver Metastasis after Watch-and-Wait Strategy in Rectal Cancer Patients with Complete Response: A Case Report.

Authors: Burlaka A Mykytyuk A Bezverkhnyi V et al.

Source: Experimental oncology [Exp Oncol] 2026 Jun 14; Vol. 48 (1), pp. 59-65. Date of Electronic Publication: 2026 Jun 14.

Publication Type: Journal Article; Case Reports

Journal Info: Publisher: Akademperiodyka Country of Publication: Ukraine NLM ID: 101230541 Publication Model: Electronic Cited Medium: Internet ISSN: 2312-8852 (Electronic) Linking ISSN: 18129269 NLM ISO Abbreviation: Exp Oncol Subsets: MEDLINE

Neoadjuvant PD-1/VEGF bispecific antibody combined with chemotherapy for locally advanced pulmonary lymphoepithelioma-like carcinoma achieving pathological complete response: a case report and literature review.

Authors: You Y Yang M Chen Z et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 12; Vol. 17, pp. 1826272. Date of Electronic Publication: 2026 Jun 12 (Print Publication: 2026).

Publication Type: Journal Article; Case Reports; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer.

Authors: Zhang S Zhang H Dong X et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 08; Vol. 17, pp. 1866469. Date of Electronic Publication: 2026 Jun 08 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE